medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2010, Number 6

<< Back Next >>

Rev Invest Clin 2010; 62 (6)

CFTR allelic heterogeneity in Mexican patients with cystic fibrosis: implications for molecular screening

Chávez-Saldaña M, Yokoyama E, Lezana JL, Carnevale A, Macías M, Vigueras RM, López M, Orozco L

Language: English
References: 32
Page: 546-552
PDF size: 83.40 Kb.


ABSTRACT

Introduction. Cystic fibrosis, the most common autosomal recessive disorder, is caused by defects in the CF transmembrane conductance regulator gene (CFTR) that encodes a chloride channel. To date, over 1,800 mutations have been described related to the causative gene of CF, showing a variable frequency among populations. In a previous extensive analysis of the CFTR locus in 97 Mexican patients, 34 different mutations (75% of CF alleles) were found using several strategies for mutation screening; however, 63% had at least an uncharacterized allele. Despite the combined technologies used, there are still a great number of unknown mutations in the Mexican population. Objective. Screening of the CFTR gene to provide additional evidence of the mutational wide spectrum responsible for CF in Mexican patients. Material and Methods. In this study, the number of unrelated CF patients was increased to 230, 133 new cases and the 97 previously reported to include 63% with at least an uncharacterized allele. Additional tools were used to improve the detection rate of CF mutations, such as a commercial kit for 36 mutations plus a single chain conformational polymorphism method and DNA sequencing. Results. By using a combination of these strategies we characterized 77.7% of all the CF alleles, resulting in a total of 46 different mutations detected, including the identification of 12 additional mutations (p.R334W, p.A455E, c.3120+1G › A, c.3272-26A › G, c.711+1G › T, p.Q552X, p.W1282X, c.IVS8-5T, p.R1162X and p.R347P, p.D1152H and p.T1036N). Although these 12 mutations have been reported in other populations, they have not yet been reported in Mexican patients. This report shows that Mexico has one of the widest spectra of CFTR mutations worldwide. The knowledge of the ethnic and geographic distribution of CFTR mutations in this population will allow the development of more effective methods for diagnosis and treatment.


REFERENCES

  1. Cutting GR. Cystic fibrosis. In: Rimoin DL, Connor MJ, Pyeritz RE (Eds.). Principles and practice of medical genetics. 5th Ed. London: Churchill-Livingston: Emery and Rimon’s; 2007, p. 1561-606.

  2. Welsh MJ, Ramsey BW, Accuso F, Cutting GR. Cystic fibrosis. In: C Scriver, A Beaudet, W Sly, D Valle (Eds.) The metabolic and molecular bases of inherited disease. 8th Ed. New York: McGraw-Hill Co; 2001, p. 5121-88.

  3. Accurso FJ. Update in cystic fibrosis 2007. Am J Respir Crit Care Med 2008; 177: 1058-61.

  4. Schrijver I, Ramalingman S, Sankaran R, Swanson S, Dunlop CLM, Keiles S, Moss RB, et al. Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics. J Mol Diag 2005; 7(2): 289-99.

  5. Kerem E, Kerem B. Genotype-Phenotype correlation in cystic fibrosis. Pediatric Pulmonology 1996; 22: 387-95.

  6. Braun AT, FarrelPM, Ferec C, Audrezet MP, Lxova A, Li Z, Kosorok MR, et al. Cystic fibrosis mutation and genotype-pulmonary phenotype analysis. J Cystic Fibrosis 2006; 5: 33-41.

  7. Cystic Fibrosis Genetic Analysis Consortium. http//www.genet.sickkids.on.ca

  8. Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: A world wide analysis of the CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002; 19: 575-606.

  9. Orozco L, Velázquez R, Zielenski J, Tsui LCH, Chávez M, Lezana JL, Saldaña Y, Hernández E, Carnevale A. Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1098C, 846delT, P750L, 4160ins- GGGG and 297-1G®A). Hum Genet 2000; 106: 360-65.

  10. Stuhrmenn M, Dörk T, Frühwirth M, Golla A, Skawran B, Antoni W, Ebhardt M, et al. Detection of 100% of the CFTR mutations in 63 CF families from Tyrol. Clin Genet 2008; 52(4): 240-6.

  11. Storm K, Moens E, Vits L, De Vlieger H, Delaere G, D’Hollander M, Wuyts W, et al. High incidence of the CFTR mutations 3272- 26A→G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A→G E588V, and 1671insTATCA). J Cyst Fibros 2007; 6(6): 371-5.

  12. Duguépéroux I, Bellis G, Férec C, Gillet D, Scotet V, De Braekeleer M. Relationship between genotype and phenotype for the CFTR gene W846X mutation. J Med Genet 2002; 39(6). On line doi:10.1136/jmg.39.6.e32.

  13. Quint A, Lerer I, Sagi M, Abeliovich D. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening. Am J Med Genet A 2005; 136(3): 246-8.

  14. Raskin S, Pereira-Ferrari L, Reis FC, Abreu F, Marostica P, Rozov T, Cardieri J, et al. Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p.F508del, mutation at the CFTR gene in newborns and patients. J Cyst Fibros 2008; 7(1): 15-22.

  15. Jay LM, Mateus H, Fonseca D, Restrepo CM, Keyeux G. PCRheterodúplex por agrupamiento: Implementación de un método de identificación de portadores de la mutación más común causal de fibrosis quística en Colombia. Colomb Med 2006; 37 (3): 176-82.

  16. Luzardo G, Aznarez I, Crispino B, Mimbacas A, Martínez L, Poggio R, Zielenski J, et al. Cystic fibrosis in Uruguay. Genet Mol Res 2002; 1(1): 32-8.

  17. Ramírez O, Ghio A, Melano A, De Botelli M, Dodelson R. Molecular diagnosis of cystic fibrosis in 93 Argentinean patients and detection of heterozygotes in affected families. Impact on health services and therapeutic advances. Arch Argent Pediatr 2008; 106(4): 310-9.

  18. Valle EP, Burgos RI, Valle JR, Béjar DE, Ruí-Cabezas JC. Analysis of CFTR gene mutations and cystic fibrosis incidence in the Ecuatorian population. Invest Clin 2007; 48(1): 91-8.

  19. Castellani C, Cuppens H, Macek M, Cassiman JJ, Kerem E, Durie P, Tullis E, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008; 7: 179-96.

  20. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilorcarpine iontophoresis. Pediatrics 1959; 23: 545-9.

  21. Decaestecker K, Decaestecker E, Castellani C, Jaspers M, Cuppens H, De Boeck K. Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients. Eur Respir J 2004; 23: 679-84.

  22. Blin N, Sttaford D. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acid Res 1976; 3: 2303-8.

  23. Heaney DL, Flume P, Hamilton L, Lyon E, Wolff DJ. Consultation in Molecular Diagnostics. J Molecular Diagnosis 2006; 8(1): 137-40.

  24. Orita MS, Suski Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-9.

  25. Sanz J, Steiner B, Gallati S. Two buffer system-based SSCP/HD analysis of DNA and RNA: a general protocol for rapid and sensitive mutation screening in cystic fibrosis. The European Working Group on CFTR Expression 2003:1-9.

  26. HGVS. Human Genome Variation Society, 2006; Retrieved December 12, 2006 from http://www.genomic.unimelb.edu.au/mdi/

  27. Lisker R, Ramírez E, Pérez-Briceño R, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol 1990; 62: 791-801.

  28. Orozco L, Zielenski, Markiewicz D, Villarreal T, Tsui L-Ch, Lezana JL, Del Angel RM. Two Novel Frameshift Deletions (1924del7, 2055del9-A) in CFTR Gene in Mexican Cystic Fibrosis Patients. Hum Mut 1997; 10: 239-40.

  29. Loumi O, Ferec C, Mercier B, Creff J, Fercort B, Denine R, Grangaud JP. CFTR mutations in Algerian population. J Cyst Fibros 2008; 7(1): 54-9.

  30. Dequeker E, Stuhrmann M, Morris M, Casals T, Castellani C, Claustres M, Cuppens H, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders- updated European recommendations. Eur J Hum Genet 2009; 17: 51-65.

  31. Pérez MM, Luna MC, Piveta OH, KeyeuxG. CFTR gene analysis in Latin American CF patients: Heterogeneous origin and distribution of mutations across the continent. J Cyst Fibros 2007; 6(3): 194-208.

  32. Alonso M, Heine-Suñer D, Calvo M, RosellJ, Giménez J, Ramos MD, et al. Spectrum of mutations in the CFTR Gene in cystic fibrosis patients of Spanish ancestry. Ann Hum Genet 2007; 71(2): 194-201.




2020     |     www.medigraphic.com